11736
G. Mancilla et al. / Tetrahedron 64 (2008) 11732–11737
67.1 (t, C-1), 112.2 (d, C-600), 116.4 (d, C-200), 120.5 (d, C-400), 123.0 (s,
C-300), 126.6 (2d, C-20, C-60), 127.7 (d, C-40), 128.8 (2d, C-30, C-50),
130.4 (d, C-500), 139.4 (s, C-10), 148.5 (s, C-100); HMBC (selected cor-
relations): C-100/H-2; C-20, C-60/H-2; MS (EI) m/z (relative in-
2/H-10; C-1/CH3-2%; C-4/CH3-2IV; C-200, C-600/H-10; C-1%/
ꢂ
H-6; C-1IV/H-3, H-5; MS (EI) m/z (relative intensity): 329 [M]þ
(2), 311 (9), 298 [MꢁCH2OH]þ (72), 266 (100), 238 (14), 207
[NHC6H4(CO2Me)2]þ (21), 177 (34), 150 (16), 119 [PhCHCH2OH]þ
(18), 104 (22), 91 [C7H7]þ (38), 77 [C6H5]þ (18); HRMS m/z: ob-
served 329.1280 [M]þ; C18H19NO5 requires 329.1263.
ꢂ
tensity): 291/293 [M]þ (5/4), 273/275 (8/6), 260/262 [MꢁCH2OH]þ
(100/80), 182 (24), 180 (23), 155/157 [C6H4Br]þ (24/20), 103 (20), 91
[C7H7]þ (38), 77 [C6H5]þ (32); HRMS m/z: observed 291.0255 [M]þ;
C14H14NOBr requires 291.0259.
Acknowledgements
4.3.5. Methyl 2-(20-hydroxyethyl-10-phenyl-amino)benzoate (6j)
This research was supported by grants from MEC, AGL2006-
Yellow solid; mp 78–80 ꢀC; IR (KBr) nmax (cmꢁ1): 3357 (
n
O–H),
´
13401-C02-01/AGR, and the Junta de Andalucıa, P07-FQM-02689
2877 (
matic ring); 1255 (
d
n C–H, N–CH2), 1684 (n C]O ester), 1581, 1516 (n C]C aro-
´
(Spain). G.M. thanks CONACYT (Mexico) and the Fundacion Caro-
n
C–O–C ester); 1H NMR (400 MHz, C6D6):
lina (Spain) for a studentship.
(ppm) 2.63 (br s, 1H, OH), 3.86 (dd, J¼6.6, 11.1 Hz, 1H, H-20b), 3.90
(s, 3H, CO2CH3), 3.94 (dd, J¼4.5, 11.1 Hz, 1H, H-20a), 4.65 (dd, J¼4.5,
6.6 Hz, 1H, H-10), 6.49 (dd, J¼1.1, 8.6 Hz, 1H, H-3), 6.57 (ddd, J¼1.1,
7.1, 8.1 Hz, 1H, H-5), 7.18 (ddd, J¼1.6, 7.1, 8.6 Hz, 1H, H-4), 7.26 (m,
1H, H-400), 7.31–7.38 (4H, H-200, H-300, H-500, H-600), 7.91 (dd, J¼1.6,
8.1 Hz, 1H, H-6), 8.49 (br s, 1H, NH); 13C NMR (100 MHz, C6D6):
References and notes
1. For selected examples, see: (a) Bestatin (immunomodulant): Bergmeier, S. C.;
Stanchina, D. M. J. Org. Chem. 1999, 64, 2852–2859; (b) Sphingosine (cell sig-
nalling): Abraham, E.; Davies, S. G.; Millican, N. L.; Nicholson, R. L.; Roberts, P.
M.; Smith, A. D. Org. Biomol. Chem. 2008, 6, 1655–1664; (c) Penaresidin A (ac-
tomyosin ATPase activator): Liu, D. G.; Lin, G. Q. Tetrahedron Lett. 1999, 40, 337–
340; (d) K01-0509 B (antibacterial): Tsuchiya, S.; Sunazuka, T.; Hirose, T.; Mori,
R.; Tanaka, T.; Iwatsuki, M.; Omura, S. Org. Lett. 2006, 8, 5577–5580; (e) Usti-
loxin D (antimitotic): Sawayama, A. M.; Tanaka, H.; Wandless, T. J. J. Org. Chem.
2004, 69, 8810–8820; (f) Febrifugine (antimalarial): Katoh, M.; Matsune, R.;
Nagase, H.; Honda, T. Tetrahedron Lett. 2004, 45, 6221–6223; (g) Halaminols A–C
(antifungal): Clark, R. J.; Garson, M. J.; Hooper, J. N. A. J. Nat. Prod. 2001, 64,
1568–1571; (h) Balanol (protein kinase C inhibitor): Miyabe, H.; Torieda, M.;
Inoue, K.; Tajiri, K.; Kiguchi, T.; Naito, T. J. Org. Chem. 1998, 63, 4397–4407.
2. Peptidomimetics: (a) Gante, J. Angew. Chem., Int. Ed. Engl. 1994, 33, 1699–1720;
(b) Axel, T. N. Angew. Chem., Int. Ed. 2004, 43, 2937–2940; Aminoglycoside
antibiotics surrogates: (c) Tok, J. B. H.; Rando, R. R. J. Am. Chem. Soc. 1998, 120,
8279–8280; (d) Hanessian, S.; Szychowski, J.; Campos-Reales Pineda, N. B.;
Furtos, A.; Keillor, J. W. Bioorg. Med. Chem. Lett. 2007, 17, 3221–3225 Human
NOS inhibitor: (e) Hallinan, E. A.; Tsymbalov, S.; Finnegan, P. M.; Moore, W. M.;
Jerome, G. M.; Currie, M. G.; Pitzele, B. S. J. Med. Chem. 1998, 41, 775–777.
3. (a) McManus, H. A.; Guiry, P. J. Chem. Rev. 2004, 104, 4151–4202; (b) Kacprzak,
K.; Ski, J. Synthesis 2001, 961–998; (c) Fache, F.; Schulz, E.; Tommasino, M. L.;
Lemaire, M. Chem. Rev. 2000, 100, 2159–2232; (d) Ager, D. J.; Prakash, I.; Schaad,
D. R. Chem. Rev. 1996, 96, 835–876.
4. Dondoni, A.; Massi, A. Angew. Chem., Int. Ed. 2008, 47, 4638–4660; (b) Mielgo,
A.; Palomo, C. Chem. Asian J. 2008, 3, 922–948; (c) Pellissier, H. Tetrahedron
2007, 63, 9267–9331.
5. (a) Boa, A. N.; Clark, S.; Hirst, P. H. Tetrahedron Lett. 2003, 44, 9299; (b) Hanson,
R. M. Chem. Rev. 1991, 91, 437–476; (c) Mitsunobu, O. In Comprehensive Organic
Synthesis; Trost, B. M., Fleming, I., Eds.; Pergamon: Oxford, 1991; Vol. 6, pp 88–
93; (d) Deyrup, J. A.; Moyer, C. L. J. Org. Chem. 1969, 34, 175–179; (e) Freifelder,
M.; Stone, G. R. J. Org. Chem. 1961, 26, 1477–1480.
6. Cossy, J.; Bellosta, V.; Hamoir, C.; Desmurs, J. R. Tetrahedron Lett. 2002, 43, 7083–
7086 and references cited therein.
7. Chakraborti, A. K.; Kondaskar, A.; Rudrawar, S. Tetrahedron 2004, 60, 9085–9091
and references cited therein.
8. (a) Zr(DS)4: Bonollo, S.; Fringuelli, F.; Pizzo, F.; Vaccaro, L. Synlett 2007, 2683–
2686; (b) RuCl3: De, S. K.; Gibbs, R. A. Synth. Commun. 2005, 35, 2675–2680; (c)
Silica gel: Chakraborti, A. K.; Rudrawar, S.; Kondaskar, A. Org. Biomol. Chem.
2004, 2, 1277–1280; (d) [Bmim]BF4: Yadav, J. S.; Reddy, B. V. S.; Basak, A. K.;
Venkat Narsaiah, A. Tetrahedron Lett. 2003, 44, 1047–1050; (e) Monodispersed
silica nanoparticles: Sreedhar, B.; Radhika, P.; Neelima, B.; Hebalkar, N. J. Mol.
Catal. A: Chem. 2007, 272, 159–163 Heteropoly acids: (f) Kumar, S. R.; Leelavathi,
P. J. Mol. Catal. A: Chem. 2007, 266, 65–68; (g) Azizi, N.; Saidi, M. R. Tetrahedron
2007, 63, 888–891; (h) NbCl5: Narsaiah, A. V.; Sreenu, D.; Nagaiah, K. Synth.
Commun. 2006, 36, 3183–3189; (i) SnCl2$H2O: Alam, M. M.; Varala, R.; Enugala,
R.; Adapa, S. R. Lett. Org. Chem. 2006, 3, 187–190; (j) Sulfamic acid: Kamal, A.;
Prasad, B. R.; Reddy, A. M.; Khan, M. N. Catal. Commun. 2007, 8, 1876–1880; (k)
(NH4)8[CeW10O36]$20H2O: Mirkhani, V.; Tangestaninejad, S.; Yadollahi, B.;
Alipanah, L. Catal. Lett. 2005, 101, 93–97; (l) H3PW12O40: Babu, K. S.; Raju, B. C.;
Kumar, S. P.; Mallur, S. G.; Reddy, S. V.; Rao, J. M. Synth. Commun. 2005, 35, 879–
885; (m) ZnBBATOH: Eshghi, H.; Rahimizadeh, M.; Shoryabi, A. Synth. Commun.
d
(ppm) 51.5 (q, CO2CH3), 59.1 (d, C-10), 67.2 (t, C-20), 110.5 (s, C-1),
112.6 (d, C-3), 115.1 (d, C-5), 126.6 (2C, d, C-200, C-600), 127.4 (d, C-400),
128.6 (2C, d, C-300, C-500), 131.4 (d, C-6), 134.4 (d, C-4), 139.9 (s, C-100),
150.2 (s, C-2), 169.1 (s, CO2CH3); HMBC (selection of correlations):
C-2/H-10; C-100/H-10, H-20a, H-20b; C-200, C-600/H-10; MS (EI) m/z
ꢂ
(relative intensity): 271 [M]þ (3), 253 [MꢁOH]þ (15), 240
[MꢁCH2OH]þ (52), 224 (24), 208 (100), 180 (23), 151
[NHC6H5CO2Me]þ (22), 119 (30), 104 (24), 92 (24), 91 [C7H7]þ (40),
ꢂ
77 [C6H5]þ (36); HRMS m/z: observed 271.1215 [M]þ ; C16H17NO3
requires 271.1208.
4.3.6. Dimethyl 5-(20-hydroxyethyl-10-phenyl-amino)-
isophthalate (6k)
Yellow solid; mp 136–141 ꢀC; IR (KBr) nmax (cmꢁ1): 3386 (
n
O–
H), 2871 (
aromatic ring), 1246, 1024 (
n C–H, N–CH2), 1718 (n C]O ester), 1605, 1438 (n
C]C
n
C–O–C ester); 1H NMR (400 MHz,
C6D6):
d
(ppm) 2.21 (sa, 1H, OH), 3.81 (dd, J¼6.7, 11.2 Hz, 1H, H-20b),
3.86 (s, 6H, CH3-2%, CH3-2IV), 3.97 (dd, J¼4.1, 11.2 Hz, 1H, H-20a),
4.60 (dd, J¼4.1, 6.7 Hz, 1H, H-10), 4.84 (sa, 1H, NH), 7.27 (m, 1H, H-
400), 7.35 (m, 4H, H-200, H-300, H-500, H-600), 7.41 (d, J¼1.6 Hz, 2H, H-4,
H-6), 7.96 (t, J¼1.6 Hz, 1H, H-2); 13C NMR (100 MHz, C6D6):
d (ppm)
52.2 (2c, CH3-2%, CH3-2IV), 59.5 (d, C-10), 67.0 (t, C-20), 118.5 (2d, C-
4, C-6), 119.7 (d, C-2), 126.7 (2d, C-200, C-600), 127.8 (d, C-400), 128.9
(2d, C-300, C-500), 131.1 (2s, C-1, C-3), 139.2 (s, C-100), 147.5 (s, C-5),
166.7 (2s, C-1%, C-1IV); HMBC (selected correlations): C-100/H-10,
2H-20; C-200, C-600/H-10; C-1%/H-2, H-6; C-1IV/H-2, H-4; MS
ꢂ
(EI) m/z (relative intensity): 329 [M]þ (3), 311 (10), 298
[MꢁCH2OH]þ (100), 281 (20), 220 (18), 209 (19), 207
[NHC6H4(CO2Me)2]þ (48), 193 [C6H4(CO2Me)2]þ (17), 178 (20), 150
(10), 133 (12), 103 (16), 91 [C7H7]þ (33), 77 [C6H5]þ (14); HRMS m/z:
observed 329.1291 [M]þ; C18H19NO5 requires 329.1263.
4.3.7. Dimethyl 2-(20-hydroxyethyl-10-phenyl-amino)-
terephthalate (6m)
Yellow solid; mp 147–149 ꢀC; IR (KBr) nmax (cmꢁ1): 3358 (
n
O–
H), 2877 (
aromatic ring), 1245 (
n C–H, N–CH2), 1691 (n C]O ester), 1578, 1450 (n
C]C
n
C–O–C ester); 1H NMR (400 MHz, C6D6):
(ppm) 3.81 (s, 3H, CH3-2%), 3.89 (dd, J¼6.8, 11.2 Hz, 1H, H-20b),
2005, 35, 791–798; (n) K5CoW12O40$3H2O: Rafiee, E.; Tangestaninejad, S.;
Habibi, M. H.; Mirkhani, V. Synth. Commun. 2004, 34, 3673–3681.
d
3.92 (s, 3H, CH3-2IV), 3.98 (dd, J¼6.4, 6.8 Hz, 1H, H20a), 4.74 (dd,
J¼6.4, 11.2 Hz, 1H, H-10), 7.17 (dd, J¼1.4, 8.4 Hz, 1H, H-5), 7.22 (d,
J¼1.4 Hz, 1H, H-3), 7.26 (m, 1H, H-400), 7.36 (4H, H-200, H-300, H-500, H-
600), 7.95 (d, J¼8.4 Hz, 1H, H-6), 8.55 (br s, 1H, NH); 13C NMR
9. CoCl2: (a) Sundararajan, G.; Vijayakrishna, K.; Varghese, B. Tetrahedron Lett.
2004, 45, 8253–8256; (b) Iqbal, J.; Pandey, A. Tetrahedron Lett. 1990, 31, 575–
576; (c) SmI2: Carree, F.; Gil, R.; Collin, J. Tetrahedron Lett. 2004, 45, 7749–7751;
(d) InBr3: Rodriguez, J. R.; Navarro, A. Tetrahedron Lett. 2004, 45, 7495–7498; (e)
Al(DS)3$H2O: Firouzabadi, H.; Iranpoor, N.; Khoshnood, A. J. Mol. Catal. A: Chem.
2007, 274, 109–115; (f) Transition metal-based Lewis acids: Zhao, P. Q.; Xu, L.
W.; Xia, C. G. Synlett 2004, 846–850; (g) ZrCl4: Swamy, N. R.; Goud, T. V.; Reddy,
S. M.; Krishnaiah, P.; Venkateswarlu, Y. Synth. Commun. 2004, 34, 727–734; (h)
Mesoporous aluminosilicate: Robinson, M. W. C.; Timms, D. A.; Williams, S. M.;
Graham, A. E. Tetrahedron Lett. 2007, 48, 6249–6251 BiCl3: (i) Ollevier, T.; Lavie-
Compin, G. Tetrahedron Lett. 2002, 43, 7891–7893; (j) Swamy, N. R.; Kondaji, G.;
(100 MHz, C6D6):
d
(ppm) 51.9 (q, CH3-2IV), 52.2 (q, CH3-2%), 58.9
(d, C-10), 67.2 (t, C-20), 113.76 (d, C-3), 113.83 (s, C-1), 115.6 (d, C-5),
126.7 (2C, d, C-200, C-600), 127.8 (d, C-400), 128.9 (2C, d, C-300, C-500),
131.7 (d, C-6), 134.9 (s, C-4), 139.4 (s, C-100), 150.0 (s, C-2), 166.6 (s, C-
1IV), 168.7 (s, C-1%); HMBC (selected correlations): C-100/H-10; C-